(Q34386621)

1 August 2017

title

Serum activity of DPPIV and its expression on lymphocytes in patients with melanoma and in people with vitiligo (English)

1 reference

1 August 2017

1 reference

0 references

Ivana Z Matić

1 reference

1 August 2017

Marija Ðorđić

1 reference

1 August 2017

Nađa Grozdanić

1 reference

1 August 2017

Ana Damjanović

1 reference

1 August 2017

Branka Kolundžija

1 reference

1 August 2017

Aleksandra Erić-Nikolić

1 reference

1 August 2017

Radan Džodić

1 reference

1 August 2017

Miomir Šašić

1 reference

1 August 2017

Srđan Nikolić

1 reference

1 August 2017

Danijela Dobrosavljević

1 reference

1 August 2017

Sanvila Rašković

1 reference

1 August 2017

Slađana Andrejević

1 reference

1 August 2017

Dušica Gavrilović

1 reference

1 August 2017

Oscar J Cordero

1 reference

1 August 2017

Zorica D Juranić

1 reference

1 August 2017

publication date

21 August 2012

1 reference

1 August 2017

1 reference

1 August 2017

1 reference

1 August 2017

1 reference

CD26: a key molecule in immune regulation and autoimmune diseases

1 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464610

Examination of CD26/DPPIV, p53, and PTEN expression in thyroid follicular adenoma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464610

New perspectives on the role of vitiligo in immune responses to melanoma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464610

Potential of soluble CD26 as a serum marker for colorectal cancer detection.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464610

Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464610

On the origin of serum CD26 and its altered concentration in cancer patients.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464610

CD26 expression in mature B-cell neoplasia: its possible role as a new prognostic marker in B-CLL.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464610

Dipeptidyl peptidase IV expression in cancer and stromal cells of human esophageal squamous cell carcinomas, adenocarcinomas and squamous cell carcinoma cell lines

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464610

The role of CD26/dipeptidyl peptidase IV in cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464610

Harnessing autoimmunity (vitiligo) to treat melanoma: a myth or reality?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464610

Loss of dipeptidyl peptidase IV immunostaining discriminates malignant melanomas from deep penetrating nevi

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464610

Dipeptidyl peptidase IV in tumor progression

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464610

Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464610

The multifunctional or moonlighting protein CD26/DPPIV.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464610

A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464610

A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464610

Assay of dipeptidyl peptidase IV in serum by fluorometry of 4-methoxy-2-naphthylamine.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464610

Cell surface antigens of human melanocytes and melanoma. Expression of adenosine deaminase binding protein is extinguished with melanocyte transformation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464610

glycylprolyl β-naphthylamidase activity in human serum

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464610

Hyperglycaemia increases dipeptidyl peptidase IV activity in diabetes mellitus

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464610

Increased adhesion potency of ovarian carcinoma cells to mesothelial cells by overexpression of dipeptidyl peptidase IV.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464610

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464610

Dipeptidyl peptidase IV (DPPIV) inhibits cellular invasion of melanoma cells.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464610

Lowered serum dipeptidyl peptidase IV activity in patients with anorexia and bulimia nervosa.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464610

Dipeptidyl peptidase activity of CD26 in serum and urine as a marker of cholestasis: experimental and clinical evidence.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3464610

Dipeptidylpeptidase IV activities are elevated in prostate cancers and adjacent benign hyperplastic glands

27 October 2018

1 reference

12 December 2020

Serum dipeptidyl peptidase (DPP) IV activities in oral cancer patients

1 reference

12 December 2020

Significant lower VVH7-like immunoreactivity serum level in diabetic patients: evidence for independence from metabolic control and three key enzymes in hemorphin metabolism, cathepsin D, ACE and DPP-IV

1 reference

12 December 2020

Decreased soluble dipeptidyl peptidase IV activity as a potential serum biomarker for COPD

1 reference

12 December 2020

Serum activity of dipeptidyl peptidase IV (DPPIV; EC 3.4.14.5) in breast-fed infants with symptoms of allergy

1 reference

12 December 2020

Dipeptidyl peptidase IV activity in patients with ACE-inhibitor-associated angioedema

1 reference

12 December 2020

Reference values for plasma dipeptidyl-peptidase IV activity and their association with other laboratory parameters

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2172-13-48

1 reference

Dimensions Publication ID

1 August 2017

0 references

1 reference

1 August 2017

1 reference